Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$662,200
-$110,000 QoQ
Shares Held
27,500
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#1,565
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SECTORAL ASSET MANAGEMENT INC holds $26,299,020 across 9 Drug Manufacturers - General names. PFE ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,354 | $7,621,178 | |
| 2 | JNJ |
Johnson & Johnson
|
18,218 | $4,626,825 | |
| 3 | AMGN |
Amgen Inc
|
9,210 | $3,335,125 | |
| 4 | ABBV |
AbbVie Inc.
|
12,200 | $3,070,008 | |
| 5 | MRK |
Merck & Co., Inc.
|
21,480 | $2,760,180 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
20,620 | $2,605,130 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
21,150 | $1,218,663 | |
| 8 | PFE |
Pfizer Inc
This page
|
27,500 | $662,200 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $662,200 | 27,500 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $772,200 | 27,500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $676,035 | 27,150 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,965,782 | 77,150 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,870,116 | 77,150 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,511,531 | 59,650 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,060,054 | 77,650 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,317,971 | 114,650 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,075,572 | 181,400 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,255,850 | 189,400 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $5,452,826 | 189,400 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,220,958 | 157,400 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,773,432 | 157,400 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,421,920 | 157,400 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,630,456 | 129,400 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $5,662,544 | 129,400 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,784,442 | 129,400 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,572,273 | 184,900 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $12,306,020 | 208,400 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,199,909 | 120,900 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,573,544 | 193,400 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,166,502 | 87,400 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,493,269 | 94,900 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,106,725 | 111,900 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $7,223,437 | 220,900 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,142,398 | 35,000 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||